Lifevantage (NASDAQ:LFVN) Upgraded to "Hold" at Zacks Research

Lifevantage logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research upgraded Lifevantage from “strong sell” to “hold.” Across analysts, the stock has an average “hold” rating and a consensus price target of $6.75.
  • Lifevantage reported quarterly EPS of $0.05, below the $0.06 consensus estimate, and revenue of $37.12 million versus expectations of $40.49 million.
  • Shares opened at $4.78, below their 50-day and 200-day moving averages of $5.87 and $5.85, respectively.
  • MarketBeat previews the top five stocks to own by December 1st.

Lifevantage (NASDAQ:LFVN - Get Free Report) was upgraded by stock analysts at Zacks Research from a "strong sell" rating to a "hold" rating in a report issued on Monday, Zacks reports.

Several other brokerages also recently issued reports on LFVN. Freedom Broker cut their price target on Lifevantage from $9.00 to $8.00 and set a "buy" rating for the company in a report on Friday, November 13th. Lake Street Capital upped their price objective on shares of Lifevantage from $5.00 to $6.00 and gave the company a "hold" rating in a report on Friday, August 28th. Weiss Ratings lowered shares of Lifevantage from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday. Finally, UBS Group set a $8.00 target price on shares of Lifevantage in a research note on Friday. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Lifevantage currently has an average rating of "Hold" and a consensus target price of $6.75.

Check Out Our Latest Analysis on LFVN

Lifevantage Stock Up 0.2%

Shares of NASDAQ LFVN opened at $4.78 on Monday. The business's 50 day moving average price is $5.87 and its two-hundred day moving average price is $5.85. The company has a market cap of $60.61 million, a PE ratio of 11.09 and a beta of 0.71. Lifevantage has a twelve month low of $3.90 and a twelve month high of $11.71.

Lifevantage (NASDAQ:LFVN - Get Free Report) last released its quarterly earnings data on Monday, November 9th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by ($0.01). Lifevantage had a net margin of 1.58% and a return on equity of 16.35%. The business had revenue of $37.12 million during the quarter, compared to analyst estimates of $40.49 million.

Insider Buying and Selling at Lifevantage

In other Lifevantage news, Director Michael Beindorff sold 10,000 shares of the company's stock in a transaction on Thursday, November 12th. The stock was sold at an average price of $4.89, for a total value of $48,900.00. Following the transaction, the director directly owned 31,625 shares of the company's stock, valued at $154,646.25. This represents a 24.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Kristen Cunningham sold 8,901 shares of the company's stock in a transaction on Monday, September 14th. The shares were sold at an average price of $6.18, for a total value of $55,008.18. Following the completion of the transaction, the insider directly owned 120,162 shares in the company, valued at approximately $742,601.16. This represents a 6.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 19,001 shares of company stock valued at $104,549 over the last 90 days. 13.58% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Lifevantage

Institutional investors and hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp boosted its holdings in Lifevantage by 11.9% in the 1st quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company's stock valued at $145,000 after purchasing an additional 3,571 shares during the period. Engineers Gate Manager LP grew its position in shares of Lifevantage by 109.7% during the 2nd quarter. Engineers Gate Manager LP now owns 27,009 shares of the company's stock worth $169,000 after purchasing an additional 14,131 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Lifevantage by 24.3% during the first quarter. Bank of America Corp DE now owns 23,445 shares of the company's stock worth $101,000 after purchasing an additional 4,586 shares during the period. Finally, Hsbc Holdings PLC bought a new position in shares of Lifevantage during the first quarter worth approximately $51,000. 35.32% of the stock is currently owned by institutional investors and hedge funds.

Lifevantage Company Profile

(Get Free Report)

LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company's focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lifevantage Right Now?

Before you consider Lifevantage, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.

While Lifevantage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines